Wu, a native of Qingzhou, Shandong Province, is currently a professor at PLA Army Medical University, engaged in immunology research. Wu studied in the Second Military Medical University of China People's Liberation Army from August 6 to August 65, 2006. 1September 1984 to1August 1986, served as teaching assistant in the Department of Epidemiology, Third Military Medical University of Chinese People's Liberation Army; 65438+September 0986-65438+July 0989 studied in the Third Military Medical University of PLA, and obtained a master's degree in epidemiology after graduation.
Wu has been engaged in immunology research for 35 years. Focusing on the regulation of specific immune response, the internal and external regulation mechanisms of T cells (including the first, second and third signals) were systematically studied, and the theory and system of antigen engineering technology were established internationally, and the new subgroup of T cells and the new regulation mechanism of T cell differentiation fate were discovered for the first time.
Wu's scientific research achievements
To solve the problem of "regulation of T cell differentiation and fate", Wu discovered its new subgroup and its transcription regulation mechanism for the first time, so he took the lead in naming it Tfc in the world, and applied it to clinical treatment trials of tumors, chronic hepatitis B and other diseases, and established protein's antigen engineering theory and technical system.
The virus epitope database and supertype database are established. By March 2022, 1 1 a new artificial intelligence method based on big data was invented, which realized the rapid disassembly, assembly and adjustment of virus antigen at epitope level. Quickly find epitope-antibody pairs for immunodiagnosis, cooperate to develop new immunodiagnosis products 10, and obtain registration certificate and EU CE certificate, totaling 12.